Delivery Footprint Global adoption of FzioMed’s adhesion barrier gels with presence in over 70 countries presents cross-border selling opportunities for distributors and regional sales partners, especially in spine, orthopedics, peritoneal and gynecological surgery markets.

Clinical Leadership Strong track record of nearly one million patients treated since 2002 and a focus on post-surgical adhesion prevention positions the company as a premium solution for hospitals and surgical centers aiming to reduce complications and readmissions.

USA-Made Advantage Manufacturing in the USA and a patented dual-polymer technology can be leveraged to target procurement programs emphasizing domestic production, quality controls, and regulatory familiarity for hospital groups and GPOs.

Strategic Growth Recent leadership appointments and active participation in global surgical congresses signal ongoing strategic expansion and product demonstrations, presenting opportunities to engage C-suite and clinical decision-makers at major events.

Culture & Recognition Consistently named a Best Place to Work in Southern California can be used to support employer branding in supplier qualification processes and to foster long-term partnerships with health systems prioritizing stable vendor relationships.